Midazolam Hydrochloride
Product Images NDC 55648-765
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Midazolam Hydrochloride (NDC 55648-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structure2 (Midazolaminjpf M Figure 02)
Chart (Midazolaminjpf M Figure 03)
Label (Midazolaminjpf M Figure 04)
This is a label of a drug called Midazolam HCI Injection, USP manufactured by Wockhardt Limited in Aurangabad, Maharashtra, India. The size of the dose is 2mg/2mL and it is distributed by NDC. The label includes a disclaimer to discard any unused portion of the medicine. There is some text that is not readable, possibly due to errors.*
Label (Midazolaminjpf M Figure 05)
This is a medication for injection called Midazolam HCI manufactured by Wockhardt Limited and distributed by Wockhardt USA LLC. It comes in a 10 mg/2 mL dosage and is prescription-only. The packaging indicates that any unused portion should be discarded. It also appears to be preservative-free. There is additional information regarding the manufacturer, including an address in India and a distribution center in New Jersey. The meaning of the final line of text is unclear.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.